Moreover, TRAIL-Cur-NPs exhibited superior efficacy in inhibiting growth of HCT116 colon carcinoma in vitro and in vivo due to the tumor targeting and synergistic effect of TRAIL and Cur. Here, TNFSF10 is linked to colon carcinoma.